Report Ocean has published a new report on the Narcolepsy Therapeutics Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers ...

The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug ...

Background and objectives: Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop oral mucositis. This is the first study to investigate the absorption ...

Other companies that have developed FLT3 inhibitors for AML include Cephalon (now part of Teva) - which reported disappointing data with its lestaurtinib candidate a couple of years ago ...

Context: Many children with attention-deficit/hyperactivity disorder (ADHD) continue to exhibit symptoms of the disorder into adolescence and adulthood. Although ADHD ...